The Most Common Types of Cancer Treated by Radiotherapy in Tobruk, Libya.

Abeer A Suliman; Sana I. Souliman; Afaf A Saleman; Eman H Suliman

doi:10.64516/0efqzg17

Authors

Abeer A Suliman Faculty of Medical Technology, University of Tobruk, Tobruk, Libya. Author
Sana I. Souliman Faculty of Medical Technology, University of Tobruk, Tobruk, Libya. Author
Afaf A Saleman Faculty of Medical Technology, University of Tobruk, Tobruk, Libya. Author
Eman H Suliman Oncology Department, Medical Tobruk centre, Tobruk, Libya. Author

DOI:

https://doi.org/10.64516/0efqzg17

Keywords:

Oncology department at Medical Tobruk Cancer, Radiotherapy, Tobruk Libya.

Abstract

This study concern wth treatment the different types of cancer by radiotherapy, and the most common type of cancer in oncology department of Medical Tobruk Centre in Libya between 2018 to 2021. In recent years, many cases of cancer have been observed in the world, and from this point of view, in this study, we searched for the most cancer in Tobruk Medical Center who received chemotherapy and radiation. Radiation therapy technology, image technology and the application of chemotherapy have evolved in the past two decades. Where radiotherapy has become an essential role and plays an important role in the series of cancer treatment after chemotherapy, and the response of patients to treatment was great, so in this study we tried to shed light on radiotherapy and the patients' at Medical Tobruk Center.In the study included 921 patients who treated by chemotherapy and radiotherap., But only 516 patients completed their follow-up to the oncology center. These patients had different types of cancer it is breast, nasopharyngeal, cervix, uterus, lung, brain and Colorectal. These patients were followed up in the oncology department at Medical Tobruk Center, where they received chemotherapy and radiotherapy. Whereas we noticed that breast cancer is the most common in the four years, Radiation therapy has a significant role in treating breast cancer in the early stages. Further studies are required to confirm these findings.

References

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.

2. Bleicher RJ, Moran MS, Ruth K, Edge SB, Dietz JM, Wilke LG, et al. The impact of radiotherapy delay in breast conservation patients not receiving chemotherapy and the rationale for dichotomizing the radiation oncology time-dependent standard into two quality measures. Ann Surg Oncol. 2021;1–13.

3. Dahele M, Tol JP, Vergeer MR, Jansen F, Lissenberg-Witte BI, Leemans CR, et al. Is the introduction of more advanced radiotherapy techniques for locally-advanced head and neck cancer associated with improved quality of life and reduced symptom burden? Radiother Oncol. 2020;151:298-303.

4. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021.

5. Han D, Gao F, Liu JL, Wang H, Fu Q, Yang GW. Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study. BMC Cancer. 2021;21(1):1–11.

6. Hussain SA, Porta N, Hall E, Salawu A, Lewis R, Sreenivasan T, et al. Outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy followed by (chemo) radiotherapy in the BC2001 trial. Eur Urol. 2021;79(2):307–15.

7. Liu Z, Yang C. A mathematical model of cancer treatment by radiotherapy. Comput Math Methods Med. 2014;2014:1–8.

8. Merrick M, Merrick MJ, Weeder C, Akhter H, Bray A, Walther A, et al. Radiotherapy and chemotherapy alter migration of brain cancer cells before cell death. bioRxiv. 2020.

9. Shafiee A, Atala A. Printing technologies for medical applications. Trends Mol Med. 2016;22(3):254–65.

10. Sung JJ, Luk AK, Ng SS, Ng AC, Chiu PK, Chan EY, et al. Effectiveness of One-Stop Screening for Colorectal, Breast, and Prostate Cancers: A Population-Based Feasibility Study. Front Oncol. 2021;11:140.